40 related articles for article (PubMed ID: 27650855)
1. Localized cytotoxic T cell-associated antigen 4 and antioxidant islet encapsulation alters macrophage signaling and induces regulatory and anergic T cells to enhance allograft survival.
Barra JM; Kozlovskaya V; Burnette KS; Banerjee RR; Fraker CA; Kharlampieva E; Tse HM
Am J Transplant; 2023 Apr; 23(4):498-511. PubMed ID: 36731781
[TBL] [Abstract][Full Text] [Related]
2. Drug Integrating Amphiphilic Nano-Assemblies: 2. Spatiotemporal Distribution within Inflammation Sites.
De Toni T; Dal Buono T; Li CM; Gonzalez GC; Chuang ST; Buchwald P; Tomei AA; Velluto D
Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794314
[TBL] [Abstract][Full Text] [Related]
3. Challenges and opportunities in the islet transplantation microenvironment: a comprehensive summary of inflammatory cytokine, immune cells, and vascular endothelial cells.
Chen QD; Liu L; Zhao XH; Liang JB; Li SW
Front Immunol; 2023; 14():1293762. PubMed ID: 38111575
[TBL] [Abstract][Full Text] [Related]
4. A Fresh Glimpse into Cartilage Immune Privilege.
Garrity C; Arzi B; Haus B; Lee CA; Vapniarsky N
Cartilage; 2022 Dec; 13(4):119-132. PubMed ID: 36250484
[TBL] [Abstract][Full Text] [Related]
5. Freeform 3D Ice Printing (3D-ICE) at the Micro Scale.
Garg A; Yerneni SS; Campbell P; LeDuc PR; Ozdoganlar OB
Adv Sci (Weinh); 2022 Sep; 9(27):e2201566. PubMed ID: 35794454
[TBL] [Abstract][Full Text] [Related]
6. Local delivery strategies to restore immune homeostasis in the context of inflammation.
Bentley ER; Little SR
Adv Drug Deliv Rev; 2021 Nov; 178():113971. PubMed ID: 34530013
[TBL] [Abstract][Full Text] [Related]
7. Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering.
Krentz NAJ; Shea LD; Huising MO; Shaw JAM
Lancet Diabetes Endocrinol; 2021 Oct; 9(10):708-724. PubMed ID: 34480875
[TBL] [Abstract][Full Text] [Related]
8. Local Immunomodulatory Strategies to Prevent Allo-Rejection in Transplantation of Insulin-Producing Cells.
Wang X; Brown NK; Wang B; Shariati K; Wang K; Fuchs S; Melero-Martin JM; Ma M
Adv Sci (Weinh); 2021 Sep; 8(17):e2003708. PubMed ID: 34258870
[TBL] [Abstract][Full Text] [Related]
9. Engineering immunomodulatory biomaterials for type 1 diabetes.
Stabler CL; Li Y; Stewart JM; Keselowsky BG
Nat Rev Mater; 2019 Jun; 4(6):429-450. PubMed ID: 32617176
[TBL] [Abstract][Full Text] [Related]
10. Rapid On-Demand Extracellular Vesicle Augmentation with Versatile Oligonucleotide Tethers.
Yerneni SS; Lathwal S; Shrestha P; Shirwan H; Matyjaszewski K; Weiss L; Yolcu ES; Campbell PG; Das SR
ACS Nano; 2019 Sep; 13(9):10555-10565. PubMed ID: 31436946
[TBL] [Abstract][Full Text] [Related]
11. Advances in immunotherapy delivery from implantable and injectable biomaterials.
Leach DG; Young S; Hartgerink JD
Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
[TBL] [Abstract][Full Text] [Related]
12. Redox-Dependent Inflammation in Islet Transplantation Rejection.
Barra JM; Tse HM
Front Endocrinol (Lausanne); 2018; 9():175. PubMed ID: 29740396
[TBL] [Abstract][Full Text] [Related]
13. Improving Vaccine and Immunotherapy Design Using Biomaterials.
Bookstaver ML; Tsai SJ; Bromberg JS; Jewell CM
Trends Immunol; 2018 Feb; 39(2):135-150. PubMed ID: 29249461
[TBL] [Abstract][Full Text] [Related]
14. Bio-synthetic materials for immunomodulation of islet transplants.
Foster GA; García AJ
Adv Drug Deliv Rev; 2017 May; 114():266-271. PubMed ID: 28532691
[TBL] [Abstract][Full Text] [Related]
15. Biopatterned CTLA4/Fc Matrices Facilitate Local Immunomodulation, Engraftment, and Glucose Homeostasis After Pancreatic Islet Transplantation.
Zhang W; Gorantla VS; Campbell PG; Li Y; Yang Y; Komatsu C; Weiss LE; Zheng XX; Solari MG
Diabetes; 2016 Dec; 65(12):3660-3666. PubMed ID: 27650855
[TBL] [Abstract][Full Text] [Related]
16. Hair follicle dermal sheath derived cells improve islet allograft survival without systemic immunosuppression.
Wang X; Hao J; Leung G; Breitkopf T; Wang E; Kwong N; Akhoundsadegh N; Warnock GL; Shapiro J; McElwee KJ
J Immunol Res; 2015; 2015():607328. PubMed ID: 26000314
[TBL] [Abstract][Full Text] [Related]
17. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.
Montane J; Obach M; Alvarez S; Bischoff L; Dai DL; Soukhatcheva G; Priatel JJ; Hardenberg G; Levings MK; Tan R; Orban PC; Verchere CB
Cell Transplant; 2015; 24(10):2143-54. PubMed ID: 26423995
[TBL] [Abstract][Full Text] [Related]
18. Immunoprotection and Functional Improvement of Allogeneic Islets in Diabetic Mice, Using a Stable Indoleamine 2,3-Dioxygenase Producing Scaffold.
Hosseini-Tabatabaei A; Jalili RB; Khosravi-Maharlooei M; Hartwell R; Kilani RT; Zhang Y; Ghahary A
Transplantation; 2015 Jul; 99(7):1341-8. PubMed ID: 25769070
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
